Annie McGuire
Human Resources Officer bij VERACYTE, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Annie McGuire is currently the Chief People Officer, EVP & General Counsel at Veracyte, Inc. Previously, she worked as the Senior Corporate Counsel at Amgen, Inc., Vice President-Legal at MyoKardia, Inc., and Secretary & General Counsel at Rakuten Medical, Inc. She obtained her undergraduate degree from Pace University and her graduate degree from New York Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERACYTE INC
0.13% | 06-03-2024 | 97 325 ( 0.13% ) | 2 M $ | 31-03-2024 |
Actieve functies van Annie McGuire
| Bedrijven | Functie | Begin |
|---|---|---|
| VERACYTE, INC. | Human Resources Officer | - |
Eerdere bekende functies van Annie McGuire
| Bedrijven | Functie | Einde |
|---|---|---|
| MYOKARDIA, INC. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Rakuten Medical, Inc.
 Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | General Counsel | - |
Opleiding van Annie McGuire
| Pace University | Undergraduate Degree |
| New York Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| VERACYTE, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Rakuten Medical, Inc.
Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Commercial Services |
